Drug Interactions — MCQs
Pharmacodynamics deals with:-
An SSRI antidepressant, such as fluoxetine, will be prescribed for an adult patient. You should advise him or her that two of the most likely side effects or adverse responses that may eventually occur at therapeutic blood levels are which of the following?
What is the mechanism of metabolism for alcohol, aspirin, and phenytoin at high doses?
All are true for cytochrome P450 enzymes EXCEPT:
A patient on SSRI sertraline was also prescribed amitriptyline and subsequently developed serotonin toxicity. What is the likely treatment for serotonin toxicity?
A 68-year-old with depression and chronic pain is on amitriptyline. What side effect may arise if given oxybutynin for overactive bladder?
A 25-year-old uncooperative patient of schizophrenia was brought in to the casualty. The Casualty Medical Officer gave an injectable drug to the patient. Two hours later patient develops the following posturing. What is the best treatment?
Clozapine is used in:
Which antipsychotic has anti-suicidal properties?
What is the drug of choice for a schizophrenic patient with poor oral absorption?
Drug Interactions Indian Medical PG Practice Questions and MCQs
Question 1: Pharmacodynamics deals with:-
- A. Latency of onset
- B. Mechanism of action of a drug (Correct Answer)
- C. Transport of drug across the biological membranes
- D. Mode of excretion of a drug
Explanation: Detailed study of the **Mechanism of action of a drug** [1][2] - **Pharmacodynamics** describes what the **drug does to the body**, including its **molecular targets** and biochemical effects [3]. - This involves the study of the drug's mechanisms to produce its therapeutic or toxic effects [2]. *Latency of onset* - **Latency of onset** refers to the time it takes for a drug to start producing its effects, which is a pharmacokinetic rather than a pharmacodynamic parameter. - It deals with the drug's absorption and distribution rather than its interaction with the body once it reaches its site of action. *Transport of drug across the biological membranes* - The **transport of drugs across biological membranes** is a key aspect of **pharmacokinetics**, specifically absorption and distribution [1]. - This process determines how much drug reaches its target site, not how it interacts with the target. *Mode of excretion of a drug* - The **mode of excretion** of a drug (e.g., renal, hepatic) falls under **pharmacokinetics**, addressing how the body gets rid of the drug. - This process influences the drug's duration of action and elimination half-life, not its mechanism of action.
Question 2: An SSRI antidepressant, such as fluoxetine, will be prescribed for an adult patient. You should advise him or her that two of the most likely side effects or adverse responses that may eventually occur at therapeutic blood levels are which of the following?
- A. Sexual dysfunction and sleep disturbances (Correct Answer)
- B. Sexual dysfunction and nausea
- C. Headache and diarrhea
- D. Tremor and weight gain
Explanation: ***Sexual dysfunction and sleep disturbances*** - **Sexual dysfunction** is one of the most common and persistent adverse effects of SSRIs, affecting 40-65% of patients and continuing throughout treatment at therapeutic levels [2], [3]. - **Sleep disturbances** (insomnia or altered sleep architecture) can persist during long-term SSRI therapy and are among the eventual side effects patients experience [1], [2], [3]. - Both effects are characteristic of chronic SSRI use and significantly impact patient compliance and quality of life. *Sexual dysfunction and nausea* - While **sexual dysfunction** is indeed very common and persistent, **nausea** is typically a transient side effect that occurs during the first 1-2 weeks of treatment and usually resolves with continued use [2]. - The question specifically asks about *eventual* occurrence at therapeutic levels over time, making nausea less appropriate as it is not a chronic issue. *Tremor and weight gain* - **Tremor** is not among the most common side effects of SSRIs and occurs less frequently than sexual dysfunction or sleep disturbances. - **Weight gain** can occur with some SSRIs (particularly paroxetine), but fluoxetine is actually considered weight-neutral or may even cause weight loss in some patients, making this combination less likely for fluoxetine specifically [1]. *Headache and diarrhea* - Both **headache** and **diarrhea** are common initial side effects when starting SSRIs but typically improve or resolve within the first few weeks of treatment [1]. - These are transient effects rather than eventual persistent side effects that characterize long-term therapeutic use.
Question 3: What is the mechanism of metabolism for alcohol, aspirin, and phenytoin at high doses?
- A. First pass kinetics
- B. First order kinetics
- C. Zero order kinetics (Correct Answer)
- D. Second order kinetics
Explanation: ***Zero order kinetics*** - This mechanism occurs when the **metabolic enzymes become saturated at high drug concentrations**, leading to a constant amount (not a constant percentage) of drug being eliminated per unit time. - Alcohol, aspirin, and phenytoin are examples of drugs that exhibit **saturable metabolism**, transitioning from first-order to zero-order kinetics at higher doses. *First pass kinetics* - This describes the **metabolism of a drug by the liver or gut wall enzymes before it reaches systemic circulation** after oral administration. - While relevant to the oral bioavailability of these drugs, it does not describe the specific mechanism of elimination at high doses. *First order kinetics* - In this mechanism, a **constant fraction or percentage of the drug is eliminated per unit of time**, meaning the rate of elimination is directly proportional to the drug concentration. - Most drugs follow first-order kinetics at therapeutic doses because metabolizing enzymes are not saturated. *Second order kinetics* - This is a **less common pharmacokinetic model** where the rate of elimination is proportional to the square of the drug concentration or involves two reactants. - It does not typically describe the common elimination patterns of most drugs, including alcohol, aspirin, and phenytoin.
Question 4: All are true for cytochrome P450 enzymes EXCEPT:
- A. Synthesize amino acids (Correct Answer)
- B. Involved in drug metabolism
- C. Present mainly in the liver
- D. Part of Phase I metabolism
Explanation: ***Synthesize amino acids*** - Cytochrome P450 enzymes are primarily involved in the **metabolism of xenobiotics** and endogenous compounds, not in the synthesis of amino acids. - **Amino acid synthesis** occurs through different metabolic pathways involving various enzymes distinct from the cytochrome P450 system. *Involved in drug metabolism* - Cytochrome P450 enzymes are a major group of enzymes crucial for the **biotransformation of numerous drugs** and other foreign compounds. - They typically catalyze **oxidation reactions**, preparing drugs for excretion. *Present mainly in the liver* - While present in many tissues, the **highest concentration and diversity** of cytochrome P450 enzymes are found in the **liver**, which is the primary site of drug metabolism. - They are also found in the gastrointestinal tract, kidney, lung, and brain, but to a lesser extent. *Part of Phase I metabolism* - Cytochrome P450 enzymes are the **principal enzymes responsible for Phase I reactions** in drug metabolism. - **Phase I metabolism** generally involves reduction, oxidation, or hydrolysis reactions to introduce polar groups to the drug molecule.
Question 5: A patient on SSRI sertraline was also prescribed amitriptyline and subsequently developed serotonin toxicity. What is the likely treatment for serotonin toxicity?
- A. Flumazenil
- B. Cyproheptadine (Correct Answer)
- C. L-Carnitine
- D. Leucovorin
- E. Naloxone
Explanation: ***Cyproheptadine*** - **Cyproheptadine** is a serotonin antagonist that can help reverse the effects of excessive serotonin in the central nervous system. - It works by blocking **serotonin 5-HT2A receptors**, which are implicated in the pathophysiology of serotonin toxicity. *Flumazenil* - **Flumazenil** is a benzodiazepine receptor antagonist used to reverse the effects of benzodiazepine overdose. - It has no role in the treatment of **serotonin toxicity**, as it does not affect serotonin pathways. *L-Carnitine* - **L-Carnitine** is a mitochondrial co-factor used in fatty acid metabolism, sometimes supplemented for certain metabolic disorders or muscle pain. - It does not have any direct action on **serotonin receptors** or the serotonin system, making it ineffective for serotonin toxicity. *Leucovorin* - **Leucovorin** (folinic acid) is used to counteract the effects of methotrexate toxicity or to enhance the effects of fluorouracil in chemotherapy. - It is not involved in modulating **neurotransmitter levels** or reversing the symptoms of serotonin toxicity. *Naloxone* - **Naloxone** is an opioid receptor antagonist used to reverse opioid overdose. - It has no effect on **serotonin receptors** or serotonergic pathways, making it ineffective for treating serotonin toxicity.
Question 6: A 68-year-old with depression and chronic pain is on amitriptyline. What side effect may arise if given oxybutynin for overactive bladder?
- A. Severe dry mouth (Correct Answer)
- B. Bradycardia
- C. Increased sweating
- D. Urinary incontinence
Explanation: ***Severe dry mouth*** - Both **amitriptyline** (a tricyclic antidepressant) and **oxybutynin** (an anticholinergic for overactive bladder) have significant anticholinergic effects. - The combination of these two drugs can lead to an additive effect, causing pronounced anticholinergic side effects such as **severe dry mouth**, blurred vision, constipation, and cognitive impairment. *Bradycardia* - **Anticholinergic drugs** typically cause **tachycardia** (increased heart rate) by blocking the parasympathetic nervous system's muscarinic receptors on the heart, rather than bradycardia. - While amitriptyline can affect cardiac conduction, severe bradycardia is not a typical **additive anticholinergic side effect** in this context. *Increased sweating* - **Anticholinergic drugs** like amitriptyline and oxybutynin inhibit the activity of sweat glands, which are primarily innervated by cholinergic nerves. - Therefore, the combination of these drugs would likely lead to **decreased sweating** (anhidrosis) rather than increased sweating. *Urinary incontinence* - **Oxybutynin** is prescribed specifically to treat **overactive bladder** and reduce urinary incontinence by relaxing the detrusor muscle. - Therefore, it would improve rather than worsen urinary incontinence; however, it can cause **urinary retention** due to its anticholinergic effect, especially in older male patients.
Question 7: A 25-year-old uncooperative patient of schizophrenia was brought in to the casualty. The Casualty Medical Officer gave an injectable drug to the patient. Two hours later patient develops the following posturing. What is the best treatment?
- A. Propranolol
- B. Dantrolene sodium
- C. Ventriculostomy
- D. Benzhexol (Correct Answer)
Explanation: ***Benzhexol*** - The patient's posturing (likely **acute dystonia**) is a common extrapyramidal side effect of typical antipsychotics, which are often given via injection to uncooperative schizophrenic patients. - **Benzhexol** (trihexyphenidyl) is an anticholinergic medication used to treat drug-induced extrapyramidal symptoms like dystonia, parkinsonism, and akathisia. - In acute dystonia, **parenteral anticholinergics** (IV diphenhydramine or IM benztropine) are typically preferred for faster onset, but benzhexol remains a valid anticholinergic treatment option. - The anticholinergic action reverses the dystonic reaction by restoring the dopamine-acetylcholine balance in the basal ganglia. *Propranolol* - **Propranolol** is a beta-blocker primarily used to treat essential tremor and some forms of drug-induced akathisia, but it is not the first-line treatment for acute dystonia. - While it can help with anxiety symptoms associated with akathisia, it has no role in managing acute dystonic reactions. *Dantrolene sodium* - **Dantrolene sodium** is a direct-acting skeletal muscle relaxant primarily used in the management of **neuroleptic malignant syndrome (NMS)** and malignant hyperthermia. - NMS is a more severe and distinct adverse reaction, involving fever, muscle rigidity, altered mental status, and autonomic dysfunction, which is not depicted here. - Acute dystonia presents much earlier (hours) compared to NMS (days to weeks) and lacks the systemic features of NMS. *Ventriculostomy* - **Ventriculostomy** is a neurosurgical procedure to relieve hydrocephalus by draining cerebrospinal fluid from the ventricles of the brain. - This procedure is entirely unrelated to the management of drug-induced extrapyramidal side effects from antipsychotic medication.
Question 8: Clozapine is used in:
- A. Depression
- B. Resistant schizophrenia (Correct Answer)
- C. Mania
- D. Delirium
Explanation: **Explanation:** **Clozapine** is an atypical (second-generation) antipsychotic and is considered the **gold standard** for the management of **Treatment-Resistant Schizophrenia (TRS)**. 1. **Why Option B is Correct:** Resistance in schizophrenia is defined as a lack of satisfactory clinical improvement despite the use of adequate doses of at least two different antipsychotics (including one atypical) for a duration of 6–8 weeks each. Clozapine is uniquely effective in these cases due to its complex receptor profile (low D2 affinity, high 5-HT2A, D4, and alpha-adrenergic blockade). It is the only antipsychotic proven to reduce suicidal behavior in schizophrenic patients. 2. **Why Other Options are Incorrect:** * **A. Depression:** First-line treatments are SSRIs/SNRIs. While some atypicals (like Quetiapine or Aripiprazole) are used as adjuncts in resistant depression, Clozapine is not used due to its side-effect profile. * **C. Mania:** Acute mania is treated with Lithium, Valproate, or standard antipsychotics (e.g., Olanzapine, Risperidone). Clozapine is reserved only for ultra-resistant cases, not as a standard indication. * **D. Delirium:** Low-dose Haloperidol is the drug of choice. Clozapine is contraindicated in delirium because its strong anticholinergic properties can worsen the confusional state. **High-Yield Clinical Pearls for NEET-PG:** * **Agranulocytosis:** The most dreaded side effect (occurs in ~1%). Mandatory **WBC monitoring** is required (weekly for the first 6 months). * **Seizures:** Clozapine carries a dose-dependent risk of seizures. * **Sialorrhea:** Paradoxical hypersalivation is a common, bothersome side effect. * **Myocarditis:** A rare but fatal side effect; monitor for tachycardia and chest pain. * **Metabolic Syndrome:** High risk of weight gain and diabetes (similar to Olanzapine).
Question 9: Which antipsychotic has anti-suicidal properties?
- A. clozapine (Correct Answer)
- B. chlorpromazine
- C. aripiprazole
- D. amisulpride
Explanation: **Explanation:** **Clozapine** is the correct answer because it is the only antipsychotic with a specifically FDA-approved indication for reducing the risk of recurrent suicidal behavior in patients with schizophrenia or schizoaffective disorder. This anti-suicidal effect is independent of its primary antipsychotic action and is believed to be mediated by its unique modulation of serotonergic (5-HT2A) and noradrenergic systems, which helps reduce impulsivity and aggression. **Analysis of Incorrect Options:** * **B. Chlorpromazine:** A typical (first-generation) antipsychotic primarily used for acute psychosis. While it treats positive symptoms, it has no proven specific anti-suicidal properties and may even worsen depressive symptoms in some patients. * **C. Aripiprazole:** A partial dopamine agonist. While effective for mood stabilization and augmentation in depression, it does not carry a specific indication for suicide prevention. * **D. Amisulpride:** A substituted benzamide that is effective for both positive and negative symptoms of schizophrenia, but lacks evidence for a direct anti-suicidal effect. **High-Yield Clinical Pearls for NEET-PG:** * **The "Rule of Two":** There are two main drugs in psychiatry known for reducing suicide risk: **Clozapine** (in Schizophrenia) and **Lithium** (in Bipolar Disorder). * **Clozapine Monitoring:** Due to the risk of **agranulocytosis**, regular monitoring of Absolute Neutrophil Count (ANC) is mandatory. * **Other Side Effects:** Clozapine is associated with the highest risk of seizures (dose-dependent), sialorrhea (drooling), myocarditis, and metabolic syndrome among antipsychotics. * **Indication:** It remains the gold standard for **Treatment-Resistant Schizophrenia** (defined as failure of two adequate trials of other antipsychotics).
Question 10: What is the drug of choice for a schizophrenic patient with poor oral absorption?
- A. Haloperidol
- B. Fluphenazine
- C. Clozapine (Correct Answer)
- D. Olanzapine
Explanation: ### Explanation **Correct Option: C. Clozapine** The core concept here is the **pharmacokinetic profile** of antipsychotics. Clozapine is unique because it undergoes extensive first-pass metabolism, but more importantly, it is the only antipsychotic where **therapeutic drug monitoring (TDM)** is frequently used to overcome absorption issues or treatment resistance. In clinical scenarios involving "poor oral absorption" (often due to gastrointestinal issues or high first-pass effect), Clozapine remains the **Drug of Choice (DOC) for treatment-resistant schizophrenia**. While other drugs have parenteral formulations, Clozapine is the gold standard for patients who fail to respond to standard therapy, which often includes those with metabolic or absorption variations that render other oral medications ineffective. **Analysis of Incorrect Options:** * **A & B (Haloperidol & Fluphenazine):** These are typical antipsychotics. While they are available as long-acting decanoate injections (useful for poor *compliance*), they are not specifically indicated for poor *absorption* over Clozapine in a refractory context. * **D. Olanzapine:** An atypical antipsychotic similar to Clozapine but lacks the same level of efficacy in treatment-resistant cases. It is often a second-line choice but does not supersede Clozapine for complex absorption/resistance profiles. **High-Yield Clinical Pearls for NEET-PG:** * **Clozapine Indications:** Treatment-resistant schizophrenia (failed 2+ antipsychotics) and reducing suicidal behavior in schizophrenia. * **Adverse Effects:** Agranulocytosis (requires mandatory ANC monitoring), seizures (dose-dependent), myocarditis, and sialorrhea (hypersalivation). * **Lacks Extrapyramidal Symptoms (EPS):** Clozapine has the lowest risk of EPS and tardive dyskinesia among all antipsychotics. * **Metabolic Syndrome:** Both Clozapine and Olanzapine carry the highest risk of weight gain and diabetes.
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free